Avantor (NYSE:AVTR) Director Purchases $83,200.00 in Stock

Avantor, Inc. (NYSE:AVTR) Director Gregory Lucier acquired 10,000 shares of the company’s stock in a transaction on Friday, May 8th. The stock was acquired at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the purchase, the director directly owned 60,000 shares of the company’s stock, valued at approximately $499,200. This trade represents a 20.00% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Avantor Stock Performance

Shares of NYSE AVTR opened at $7.89 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $5.38 billion, a P/E ratio of -9.74, a P/E/G ratio of 4.77 and a beta of 0.94. Avantor, Inc. has a 12 month low of $7.26 and a 12 month high of $15.93. The stock has a 50 day moving average of $8.02 and a 200-day moving average of $10.11.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.54 billion. During the same quarter in the prior year, the business earned $0.23 EPS. The firm’s revenue for the quarter was up .0% on a year-over-year basis. As a group, equities research analysts predict that Avantor, Inc. will post 0.79 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of Avantor from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Stifel Nicolaus set a $10.00 price target on shares of Avantor in a report on Thursday, February 12th. Citigroup cut their price objective on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Barclays reduced their price objective on Avantor from $8.50 to $7.00 and set an “underweight” rating for the company in a report on Tuesday, April 14th. Finally, TD Cowen reaffirmed a “hold” rating on shares of Avantor in a research report on Thursday, February 12th. Three equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $11.39.

Hedge Funds Weigh In On Avantor

A number of hedge funds have recently bought and sold shares of AVTR. Sei Investments Co. boosted its holdings in Avantor by 0.9% in the 1st quarter. Sei Investments Co. now owns 5,287,850 shares of the company’s stock valued at $41,457,000 after purchasing an additional 46,707 shares during the period. State of Wyoming increased its holdings in shares of Avantor by 473.0% during the first quarter. State of Wyoming now owns 34,905 shares of the company’s stock worth $274,000 after purchasing an additional 28,813 shares during the period. Cetera Investment Advisers raised its position in shares of Avantor by 34.1% in the first quarter. Cetera Investment Advisers now owns 38,569 shares of the company’s stock valued at $302,000 after buying an additional 9,799 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Avantor by 83.7% in the first quarter. PNC Financial Services Group Inc. now owns 47,157 shares of the company’s stock valued at $370,000 after buying an additional 21,481 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Avantor by 15.7% in the first quarter. Dimensional Fund Advisors LP now owns 16,894,649 shares of the company’s stock valued at $132,443,000 after buying an additional 2,288,053 shares during the period. 95.08% of the stock is owned by institutional investors.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.